🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Giving low doses of chemotherapy, such as melphalan and fludarab...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2001-07
Trial ID
NCT00027560
Severe aplastic anemia is a rare and serious form of bone marrow failure re...
Status
Recruiting
Location
Blood and Marrow Transplant Group of Georgia
Start Date
2016-09-09
Trial ID
NCT02828592
Treatments Being Tested
The primary objective is to cure multiple myeloma with less toxic allogenei...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2001-08
Trial ID
NCT00854139
RATIONALE: Giving chemotherapy drugs and total-body irradiation before a do...
Status
Terminated
Location
OHSU Knight Cancer Institute
Start Date
2004-05
Trial ID
NCT00253552
RATIONALE: Rasburicase may be an effective treatment for graft-versus-host ...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2008-01
Trial ID
NCT00513474
This is a clinical research trial in which a novel preparatory regimen was ...
Status
Terminated
Location
Thomas Jefferson University
Start Date
2009-09
Trial ID
NCT01350232
RATIONALE: Giving chemotherapy and total-body irradiation before a donor bo...
Status
Unknown
Location
Jonsson Comprehensive Cancer Center at UCLA
Start Date
2004-08
Trial ID
NCT00093587
People with severe congenital anemias, such as sickle cell anemia and beta-...
Status
Unknown
Location
National Institutes of Health Clinical Center
Start Date
2004-07-16
Trial ID
NCT00061568
This study uses transplantation to treat patients with problems in their im...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2007-01-19
Trial ID
NCT00426517
This is a single-institution, phase II study to determine the event-free su...
Status
Completed
Location
University of Minnesota Masonic Cancer Center and Medical Center
Start Date
2016-03
Trial ID
NCT02582775